Shikonin induced necroptosis in prostate cancer and glioma cell as evidenced by the enhanced phosphorylation of receptor interacting protein kinase 1, and this effect was blocked by necrostatin-1 pretreatment [13,24]. This evidence concerns the gene RIPK1 and prostate carcinoma.